These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1612747)
1. Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium. Cao Y; Wen Z; Lu D Infect Immun; 1992 Jul; 60(7):2823-7. PubMed ID: 1612747 [TBL] [Abstract][Full Text] [Related]
2. Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Stabel TJ; Mayfield JE; Tabatabai LB; Wannemuehler MJ Infect Immun; 1990 Jul; 58(7):2048-55. PubMed ID: 2114357 [TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a. Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550 [TBL] [Abstract][Full Text] [Related]
4. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice. Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219 [TBL] [Abstract][Full Text] [Related]
5. Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid. Stabel TJ; Mayfield JE; Morfitt DC; Wannemuehler MJ Infect Immun; 1993 Feb; 61(2):610-8. PubMed ID: 8423090 [TBL] [Abstract][Full Text] [Related]
6. Vi Capsular Polysaccharide Produced by Recombinant Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685 [TBL] [Abstract][Full Text] [Related]
7. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. Karem KL; Bowen J; Kuklin N; Rouse BT J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066 [TBL] [Abstract][Full Text] [Related]
9. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Karem KL; Chatfield S; Kuklin N; Rouse BT Infect Immun; 1995 Dec; 63(12):4557-63. PubMed ID: 7591105 [TBL] [Abstract][Full Text] [Related]
10. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats. Redman TK; Harmon CC; Michalek SM Infect Immun; 1994 Aug; 62(8):3162-71. PubMed ID: 8039885 [TBL] [Abstract][Full Text] [Related]
11. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter. Huang Y; Hajishengallis G; Michalek SM Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570 [TBL] [Abstract][Full Text] [Related]
12. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly. Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216 [TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909. Wang JY; Noriega FR; Galen JE; Barry E; Levine MM Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868 [TBL] [Abstract][Full Text] [Related]
14. Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent delta cya delta crp S. typhimurium. Hassan JO; Curtiss R Res Microbiol; 1990; 141(7-8):839-50. PubMed ID: 2101473 [TBL] [Abstract][Full Text] [Related]
15. Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine. Villarreal-Ramos B; Manser J; Collins RA; Dougan G; Chatfield SN; Howard CJ Vaccine; 1998 Jan; 16(1):45-54. PubMed ID: 9607008 [TBL] [Abstract][Full Text] [Related]
17. Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon. Coynault C; Robbe-Saule V; Norel F Mol Microbiol; 1996 Oct; 22(1):149-60. PubMed ID: 8899717 [TBL] [Abstract][Full Text] [Related]
18. Construction of attenuated Salmonella typhimurium Strain expressing Helicobacter pylori conservative region of adhesin antigen and its immunogenicity. Bai Y; Zhang YL; Wang JD; Zhang ZS; Zhou DY World J Gastroenterol; 2004 Sep; 10(17):2498-502. PubMed ID: 15300892 [TBL] [Abstract][Full Text] [Related]
19. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548 [TBL] [Abstract][Full Text] [Related]
20. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains. Zhang X; Kelly SM; Bollen W; Curtiss R Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]